瘤微环境向纳米药物输送系统用于多药耐药瘤治疗
Xinyue Shao1, Xiaoling Zhao1, Binghao Wang1
1Key Laboratory of Molecular Biophysics of Hebei Province, Institute of Biophysics, School of Health Sciences and Biomedical Engineering, Hebei University of Technology, 300401, Tianjin, PR China.
Theranostics
|February 3, 2025
概括
针对瘤微环境 (TME) 的纳米药物递送系统 (Nano-DDS) 正通过克服多药耐药性 (MDR) 来彻底改变癌症治疗. 这些系统利用TME特征来提高药物输送和疗效.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 药理学 药理学 是一个学科.
背景情况:
- 多药耐药性 (MDR) 仍然是癌症治疗中的一个重大挑战.
- 瘤微环境 (TME) 具有独特的病理特征,可以针对改善治疗.
- 纳米药物递送系统 (Nano-DDS) 提供了一个有希望的策略,通过准TME来克服MDR.
研究的目的:
- 为癌症治疗提供针对TME的纳米-DDS的最新进展提供全面的审查.
- 探索用于TME准的各种纳米-DDS的设计原则和特征.
- 讨论这些系统在克服癌症MDR方面的潜力.
主要方法:
- 关于针对TME的纳米DDS的当前科学文献的审查.
- 对脂质体,聚合物微粒和无机纳米载体的设计,结构和准机制的分析.
- 对研究结果的评估,这些系统在克服MDR时的有效性.
主要成果:
- 针对TME的纳米-DDS通过利用TME的特征,如缺氧和酸性pH,有效地提供治疗剂.
- 脂质体,聚合物微粒和无机纳米载体展示了各种准策略和合成创新.
- 这些系统显示出通过各种机制扭转癌症多药耐药性的巨大潜力.
结论:
- 针对TME的纳米-DDS是提高癌症治疗疗效的关键研究领域.
- 需要进一步的研究和开发来应对挑战,并优化这些系统的临床应用.
- 该综述强调了纳米-DDS在克服瘤学中耐药性的关键作用.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:27Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K